As part of our ongoing review of our editorial structure, the Topical Advisor Panel (TAP) role will be discontinued effective January 1, 2027.

Topical Advisory Panel

Members


Website
Departamento de Investigación en Polímeros y Materiales, Universidad de Sonora, Sonora, Mexico
Interests: nanocomposite hydrogels; stimuli-responsive polymers; controlled drug delivery system; multifuncional polymer systems; electroconductive polymers

Website
1. Cancer Early Detection Advanced Research (CEDAR) Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
2. Department of Molecular and Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, OR 97239, USA
Interests: cancer; nanoparticles; oncolytic and vaccine viral vector; senolytics

Website
Department of Chemistry, Federal University of Santa Maria, Avenida Roraima, 1000, Camobi, Santa Maria 97105-900, Brazil
Interests: ionic liquid; formulations; antimicrobial compounds and formulations; biomaterials; nanoparticles; surfaces and intermolecular interactions
Special Issues, Collections and Topics in MDPI journals
School of Pharmacy, University College Cork, Cork T12 YN60, Ireland
Interests: nanotechnology; drug delivery; biomaterials engineering; non-viral gene therapy; nucleic acid delivery; polymeric nanocarriers; cardiovascular disease; diabetes
Special Issues, Collections and Topics in MDPI journals

Website
Istituto Superiore di Sanità, 00161 Rome, Italy
Interests: extracellular vesicles; exosomes; T cell mediated immunity; vaccines; antigen delivery

Website
Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800 Prague, Czech Republic
Interests: population pharmacokinetics; optimization of dosing regimens; multiple sclerosis; inflammation; oxidative stress
BioX Center, School of Biosciences & Bioengineering, IIT Mandi, Kamand, Himachal Pradesh 175075, India
Interests: biomaterials; controlled delivery; bone; cartilage; necrosis; intervertebral disc; cornea; 3D printing; 3D bioprinting; bioink
The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel
Interests: brain; BBB; brain tumors; drug delivery into the brain; MRI; pulsed electric fields; electroporation
Special Issues, Collections and Topics in MDPI journals
i3S–Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
Interests: tumor microenvironment; immune modulation; nanomedicine; cancer therapy; biomaterials
Special Issues, Collections and Topics in MDPI journals

Website
Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy
Interests: regenerative medicine; tissue regeneration; cell viability; drug delivery

Website
Department of Cellular Biology, Physiology and Immunology, Faculty of Science, University of Córdoba, 14014 Cordoba, Spain
Interests: biotechnology; biochemistry; neurodegeneration and related diseases
Special Issues, Collections and Topics in MDPI journals

Website
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Interests: drug formulations; pediatrics; pediatric oncology; extemporaneous preparation; drug administration
Special Issues, Collections and Topics in MDPI journals

Website
CELLIKON, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Hartmannstraße 14, D-91052 Erlangen, Germany
Interests: dendritic cell and T cell biology; antibodies and Fc receptors; infectious diseases and vaccinations; tumor therapy
Special Issues, Collections and Topics in MDPI journals
Dept. of Clinical Pharmacy & Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169 Berlin, Germany
Interests: model-based precision dosing; pharmacometrics; translational research; nonlinear mixed-effects modelling; physiologically based pharmacokinetic modelling
Special Issues, Collections and Topics in MDPI journals

Website
Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil
Interests: spray drying and encapsulation of pharmaceuticals and phytopharmaceuticals; nanotechnology; enzyme immobilization; granulation and particle coating; process optimization
Special Issues, Collections and Topics in MDPI journals

Website
Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA
Interests: focused ultrasound; cancer immunotherapy; image-guided therapy; drug delivery; molecular imaging; image genomics (radiogenomics)
Special Issues, Collections and Topics in MDPI journals
Université Lille, Inserm, CHU Lille, U1008—Controlled Drug Delivery Systems and Biomaterials, Lille, France
Interests: biomaterial; surface functionalization; local drug delivery; biocompatibility; cytotoxicity; bone tissue engineering
Director of the Center for Bioinformatics, Simulations and Modelling (CBSM) University of Talca, Talca 3460000, Chile
Interests: ion channels; molecular modeling; drug design; drug-protein interactions; molecular dynamics

Website
Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Sukoharjo 57162, Central Java, Indonesia
Interests: pharmaceutical technology; drug safety and efficacy; drug delivery; antibiotic resistance; infectious diseases; cancer biology; medicinal plants
Special Issues, Collections and Topics in MDPI journals

Website
Department of Medical Sciences and Institute of Biomedicine – iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal
Interests: immunobiology of innate immune cells; signal transduction; cell-based therapies
Special Issues, Collections and Topics in MDPI journals
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China
Interests: artificial intelligence (AI) of pharmaceutical formulations; multi-scale modeling in drug delivery

Website
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Interests: clinical pharmaceutics; drug stability and compatibility; electrohydrodynamic atomisation; carbon nanomaterials in drug delivery and clinical assays; chitosan derivatives
American Type Culture Collection (ATCC), Manassas, VA 20110, USA
Interests: cancer biology; nanomedicine; targeted drug delivery; molecular imaging; gene silencing
Laboratorio de Nanomedicina, Instituto de Ingeniería y Tecnología, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez 32310, Mexico
Interests: pharmaceutical formulation; delivery and controlled-release systems for drugs, vaccines, and biopharmaceuticals; pharmaceutical process, engineering, biotechnology, and nanotechnology; devices, cells, molecular biology, and materials science related to drugs and drug delivery; nanomedicine; drug targeting; effects of the body on drugs (absorption, distribution, metabolism, excretion); physiological and biochemical effects of drugs on the body; systematic reviews
Special Issues, Collections and Topics in MDPI journals
Research Center for Advanced Medicine-Medfuture, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
Interests: oncology; experimental therapy; molecular biology; genomics; transcriptomics; epigenetics
Special Issues, Collections and Topics in MDPI journals
School of Pharmacy, Newcastle University, Newcastle upon Tyne, UK
Interests: cocrystallisation; solubility; formulation; multidrug formulations; mechanical behaviour of drugs
Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Interests: cellular and molecular imaging; drug and nanoparticle delivery; biomaterials; cell-based therapies
Special Issues, Collections and Topics in MDPI journals
Drug Metabolism and Pharmacokinetics, Biogen, 225 Binney Street, Cambridge, MA 02142, USA
Interests: PKPD modeling; drug-drug interaction; human dose projection; IVIVC
Special Issues, Collections and Topics in MDPI journals
AD2-027, Bernal Institute, University of Limerick, Limerick, Ireland
Interests: nanoparticles; drug process development; continuous manufacturing; final dosage formulation
Back to TopTop